NATIONAL CANCER CONTROL PROGRAMME
NOP online
ISSN 1802-887X
CANCON
 

Oncology news

Sections: Cancer research | Cancer prevention | Czech oncology | NOP On-line project

Breast tomosynthesis is not significantly different from standard digital mammography
9. 9. 2019 Institute of Biostatistics and Analyses at the Faculty of Medicine of the Masaryk University (IBA FM MU) | More information...

Digital breast tomosynthesis (DBT) is not significantly different from standard digital mammography as a screening tool for the detection of breast cancer in a population-based screening programme. The results of a Norwegian study were published in June 2019 in The Lancet Oncology [1].

Number of risky lifestyle factors is associated with an increased risk of some types of breast cancer
2. 9. 2019 Institute of Biostatistics and Analyses at the Faculty of Medicine of the Masaryk University (IBA FM MU) | More information...

Women with risky lifestyle factors have an increased risk of breast cancer overall. According to a new Norwegian study [1], this association is limited to luminal-A like and luminal B-like HER2+ subtypes of breast cancer, as opposed to luminal B-like HER2–, HER2+ or triple-negative subtypes.

INTENT: international project for innovation of cancer care in Europe
7. 6. 2019 | More information...

The INTENT project aims to find solutions for innovative patient-centered cancer care. It targets and involves various types of actors: cancer care providers, patients and policy makers. The aim is to work with these groups to create a better understanding of how to interpret the patient-centered approach and identify ways for improving cancer care in central Europe.

Millions of Europeans at risk of chronic digestive diseases, new report reveals
21. 5. 2019 UEG Press Release | More information...

Poor nutritional choices, including a high intake of ultra-processed foods and trans-fats, are putting millions of Europeans at an increased risk of a range of chronic digestive diseases, including digestive cancers, wheat related disorders and functional GI disorders, as well as obesity, a new report shows [1].

Statins linked to lower risk of early death in patients with colorectal cancer
9. 5. 2019 Wiley Press Release | More information...

Use of statins before or after a diagnosis of colorectal cancer was linked with a lower risk of premature death, both from cancer and from other causes, in a Cancer Medicine analysis of published studies [1].

Urine test could prevent cervical cancer
29. 4. 2019 University of Manchester Press Release | More information...

Urine testing may be as effective as the smear test at preventing cervical cancer, according to new research by University of Manchester scientists. The study, led by Dr Emma Crosbie and published in BMJ Open [1], found that urine testing was just as good as the cervical smear at picking up high-risk human papillomavirus (HPV), the virus that causes cervical cancer.

Experimental therapy completely clears HPV in one-third of cervical cancer precursors
3. 4. 2019 University of Michigan Press Release | More information...

A potential new immune-based therapy to treat precancers in the cervix completely eliminated both the lesion and the underlying HPV infection in a third of women enrolled in a clinical trial, according to a study published in Gynecologic Oncology [1].

Global microbial signatures for colorectal cancer
1. 4. 2019 EMBL Press Release | More information...

Cancers have long been known to arise due to environmental exposures such as unhealthy diet or smoking. Lately, the microbes living in and on our body have entered the stage as key players: while stomach cancer can be caused by a single bacterial species, Helicobacter pylori, the role that gut microbes play in the development of colorectal cancer – the third most common cancer worldwide – is less clear. To determine their influence, association studies aim to map how the microbes colonizing the gut of colorectal cancer patients are different from those that inhabit healthy subjects.

Can you “catch” cancer?
25. 3. 2019 Frontiers Press Release | More information...

Billions worldwide are infected with tropical worms. Unsurprisingly, most of these people live in poor countries, kept poor by the effects of worm-related malnourishment. What may surprise many is that worms also cause the majority of cases of some cancers in these countries. Published in Frontiers in Medicine as a special article collection on parasite-associated malignancy [1], new research aims to inform prevention and treatment – and perhaps even turn worms against cancer.

Comprehensive cancer care networks – Test driving the model in southern Czechia
17. 3. 2019 Cancerworld | More information...

What does an ideal cancer service look like and how can countries/regions make that transformation? A European collaborative project [1] spent two years trying to answer this question. The solution they came up with is now being piloted in the Czech Republic, as Sophie Fessl from Cancerworld reports [2].

Cancer in the older population of the Czech Republic
27. 10. 2015 IBA MU | More information...

Population ageing has become a challenge to cancer care in developed countries. Particularities of the older population must be taken into account when considering cancer treatment. However, there is a lack of consensus on guidelines for this population due to the underrepresentation of older patients in clinical trials.

Balance between the centralisation and availability of cancer care: Institute of Biostatistics and Analyses develops the European model of a Comprehensive Cancer Care Network
4. 5. 2015 IBA MU | More information...

The Czech Republic has become a key player in European activities focusing on the development and assessment of cancer care; the Cancer Control Joint Action (CanCon) undoubtedly belongs to the most prestigious ones. Based on the Czech information system of cancer care, the Czech Republic has been selected as a model country for the development of a Comprehensive Cancer Care Network (CCCN). This part of the CanCon project is coordinated by Prof Lucio Luzzatto from the Tumour Institute of Tuscany (Istituto Toscano Tumori, ITT), who paid a visit to Brno on 24 April 2015 not only to learn about the Czech results up to now, but also about cancer research and healthcare provided to cancer patients in the Czech Republic in general, and in the South Moravian Region in particular.

Results of personalised invitations of Czech citizens to cancer screening programmes in 2014
16. 4. 2015 Czech Ministry of Health, Institute of Biostatistics and Analyses of Masaryk University | More information...

The project of personalised invitations of citizens to cancer screening programmes was launched in the Czech Republic in January 2014. Women are invited to participate in breast cancer screening and cervical cancer screening; men and women are invited to participate in colorectal cancer screening. The project aims to enhance the current cancer prevention programmes, and to increase their participation rates; therefore, personalised invitations are sent to citizens who do not participate in cancer screening programmes in the long term, and thus are at a higher risk of developing cancer.

Cancer screening programmes and their informational support: situation in the Czech Republic in 2014
18. 12. 2014 IBA MU | More information...

A special issue of Klinicka onkologie (the official journal of the Czech Society for Oncology), published in December 2014, is dedicated to the assessment of cancer prevention efforts and results in the Czech Republic. A team of authors not only described the current situation in cancer prevention programmes in the Czech Republic, but also pointed out weak spots in cancer prevention efforts.

Another international study confirmed longer survival of Czech cancer patients
5. 12. 2014 IBA MU | More information...

Over the last 15 years, the Czech Republic has been closing the gap on Western Europe in terms of 5-year survival rates in selected cancer types, and nowadays is significantly beyond the average of other post-communist countries. The latest results from the international study CONCORD-2 have again confirmed this trend.

Cancers in 2012 due to overweight and obesity: the Czech Republic has the highest proportion in Europe
26. 11. 2014 International Agency for Research on Cancer (IARC), Institute of Biostatistics and Analyses (IBA MU) | More information...

A new study by the International Agency for Research on Cancer (IARC), the specialised cancer agency of the World Health Organization (WHO), shows that nearly half a million new cancer cases per year can be attributed to high body mass index (BMI).

Czech Cancer Care in Numbers: a brief summary
8. 10. 2014 IBA MU | More information...

A compact description of cancer care in the Czech Republic was presented at the ESMO 2014 Congress in Madrid, Spain. The Czech Society for Oncology and the Institute of Biostatistics and Analyses of the Masaryk University worked together to highlight the alarmingly growing cancer burden of the Czech population, to explain the current National Cancer Control Programme and ongoing cancer screening programmes, and to comment the latest survival rates of Czech cancer patients.

Cancer burden in the Czech Republic: European and worldwide comparison
10. 9. 2014 IBA MU | More information...

The global cancer burden is on the rise, warned IARC at the beginning of 2014. The Czech Republic is no exception: cancer incidence rates are growing in our country, too. But where does the Czech Republic rank among other European countries (or even globally) in terms of cancer burden?

Survival rates of Czech cancer patients have improved
13. 4. 2014 IBA MU | More information...

Earlier this year, two studies analysing survival rates of cancer patients in the Czech Republic and across Europe were published [12]. Survival rates of cancer patients belong to key parameters in terms of evaluation of cancer care outcomes, and of fulfilling the National Cancer Control Programme. The good news from both studies is that outcomes of the Czech cancer care have improved in most diagnoses: both in terms of time trends, and when compared to other European countries. However, there is much space for improvements in cancer prevention efforts as well as early diagnosis of less advanced stages; and last but not least, the availability of cancer diagnosis and treatment in individual regions of the Czech Republic needs to be further improved.

Tobacco consumption in the Czech Republic ranks among the highest globally, while anti-smoking measures are among the poorest worldwide
2. 4. 2014 IBA MU | More information...

Smoking is one of the most important known risk factors for cancer. Most European countries are well aware of this fact, and have adopted various measures aimed at decreasing the number of smokers among the population, which should not only improve the population’s state of health, but also save costs for treatment of smoking-related diseases. Unfortunately, international studies and comparisons have shown that the Czech Republic is miles apart from those countries.

Personalised invitations of Czech citizens to cancer screening programmes
15. 1. 2014 IBA MU | More information...

In January 2014, a project of personalised invitations for cancer screening programmes was launched in the Czech Republic. In particular, citizens are invited to participate in colorectal cancer screening (men and women), as well as breast cancer screening and cervical cancer screening (women). Personalised invitations are aimed at citizens who have not participated in cancer screening programmes in the long term, and therefore are at a higher risk of developing cancer. The project is expected to increase participation rates in Czech cancer screening programmes.

OECD Health at a Glance 2013: Czech breast cancer screening programme led to an improvement of survival rates in breast cancer patients
28. 11. 2013 IBA MU | More information...

Health at a Glance is published by OECD every two years, providing the assessment and comparison of health care in individual member countries based on clearly defined indicators. In the area of cancer care, Health at a Glance primarily focuses on three diagnoses which can be detected at early stages, and for which organised screening programmes are widely recommended: colorectal cancer, breast cancer, and cervical cancer.

New OECD publication evaluates cancer care and survival of cancer patients
21. 11. 2013 IBA MU | More information...

On 30 October 2013, OECD published “Cancer Care” [1] as a summary of indicators for care provided to cancer patients in participating countries. According to the attached “country note” for the Czech Republic [2], cancer outcomes could be further improved, despite recent improvements in survival rates of cancer patients. Estimated 5-year survival rates for selected cancers are lower than the OECD average, and mortality rates are generally high, as a result of high cancer incidence rates among the Czech population, and a relatively late diagnosis.

» Archive